OOIR: Observatory of International Research

Papers

(The median citation count of Expert Review of Proteomics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Multiomic analysis of cytokines in immuno-oncology	98
Top-down proteomics: challenges, innovations, and applications in basic and clinical research	69
Network-based strategies in metabolomics data analysis and interpretation: from molecular networking to biological interpretation	67
Analytical techniques for multiplex analysis of protein biomarkers	56
Design of engineered surfaces for prospective detection of SARS-CoV-2 using quartz crystal microbalance-based techniques	40
The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications	39
Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications	33
Nasal mucus proteome and its involvement in allergic rhinitis	33
Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspective	27
Mass spectrometric analysis to unravel the venom proteome composition of Indian snakes: opening new avenues in clinical research	24
Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic	23
Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study	22
Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade	22
A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients	21
Salivary metabolomics for cancer detection	21
Mass spectrometry-based metabolomics diagnostics – myth or reality?	20
A complete proteomic profile of human and bovine milk exosomes by liquid chromatography mass spectrometry	20
Molecular markers for cervical cancer screening	20
On the potential of micro-flow LC-MS/MS in proteomics	19
Laser Capture Proteomics: spatial tissue molecular profiling from the bench to personalized medicine	18
Studies in lung cancer cytokine proteomics: a review	18
Surveying over 100 predictors of intrinsic disorder in proteins	18
De novo sequencing of proteins by mass spectrometry	17
The potential for metabolomics in the study and treatment of major depressive disorder and related conditions	17
Proteomic studies of common chronic pain conditions - a systematic review and associated network analyses	16

Skin proteomics – analysis of the extracellular matrix in health and disease	16
Advances in the proteomic profiling of the matrisome and adhesome	16
Proteomics applications in biomarker discovery and pathogenesis for abdominal aortic aneurysm	16
Duchenne Muscular Dystrophy: recent advances in protein biomarkers and the clinical application	15
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases	15
Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants	14
The application of proteomics in muscle exercise physiology	14
Update on Proteomic approaches to uncovering virus-induced protein alterations and virus –host protein interactions during the progression of viral infection	14
Proteomics and plant biology: contributions to date and a look towards the next decade	14
Use of omic technologies in early life gastrointestinal health and disease: from bench to bedside	13
Replication of single-cell proteomics data reveals important computational challenges	13
Characterization of tick salivary gland and saliva alphagalactome reveals candidate alpha-gal syndrome disease biomarkers	12
Protein lysine acetylation and its role in different human pathologies: a proteomic approach	12
Kidney stone proteomics: an update and perspectives	12
New insights into human prefrontal cortex aging with a lipidomics approach	12
Lipid droplets diversity and functions in inflammation and immune response	12
Mass spectrometry in the lipid study of cancer	12
Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells	12
Targeted urine proteomics in lupus nephritis – a meta-analysis	12
The role of proteomics in defining autoimmunity	12
An overview of technologies for MS-based proteomics-centric multi-omics	11
Protein amino-termini and how to identify them	11
The phosphoinositide code is read by a plethora of protein domains	11
Early disease biomarkers can be found using animal models urine proteomics	11
The clinical potential of prm-PASEF mass spectrometry	11
Proteomic profiling of carbonic anhydrase CA3 in skeletal muscle	10
SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics	10
Mass Spectrometry-based Biomarkers for Knee Osteoarthritis: A Systematic Review	10
Mass spectrometry-based phospholipid imaging: methods and findings	10
Proteomic exploration of cystathionine β-synthase deficiency: implications for the clinic	9
Tracing protein and proteome history with chronologies and networks: folding recapitulates evolution	9
Integration of transcriptomic and proteomic approaches for snake venom profiling	9
Insights and clinical potential of proteomics in understanding spermatogenesis	9
Deep learning approaches for data-independent acquisition proteomics	9
Deep mutagenesis in the study of COVID-19: a technical overview for the proteomics community	9
Noninvasive urine metabolomics of prostate cancer and its therapeutic approaches: a current scenario and future perspective	9
Progress regarding the context-of-use of tau as biomarker of Alzheimer’s disease and other neurodegenerative diseases	8
In vitro and in vivo analysis of metabolites involved in the TCA cycle and glutamine metabolism associated with cisplatin resistance in human lung cancer	8
Unraveling the complexity of the extracellular vesicle landscape with advanced proteomics	8
Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins	8
Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study	8
Proteomic approaches to assist in diagnosis and prognosis of oral cancer	8
Insights and prospects for ion mobility-mass spectrometry in clinical chemistry	7
Proteomic characterization of the human lens and Cataractogenesis	7
Understanding glomerular diseases through proteomics	7
Taenia solium proteins: a beautiful kaleidoscope of pro and anti-inflammatory antigens	7
Analysis of urinary exosomes applications for rare kidney disorders	6
Peptidomics and proteogenomics: background, challenges and future needs	6
Understanding the effect of carrier proteomes in single cell proteomic studies - key lessons	6
How can artificial intelligence be used for peptidomics?	6

Proximity labeling and other novel mass spectrometric approaches for spatiotemporal protein dynamics	6
Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitis	6
Strategies for mass spectrometry-based phosphoproteomics using isobaric tagging	6
An overview of lipidomics utilizing cadaver derived biological samples	5
Breast cancer glycan biomarkers: their link to tumour cell metabolism and their perspectives in clinical practice	5
Recent advances in autophagic machinery: a proteomic perspective	5
The proteomics contribution to the counter-bioterrorism toolbox in the post-COVID-19 era	5
The secrets of protein secretion: what are the key features of comparative secretomics?	5
Proteomic analysis of pancreatic ductal adenocarcinoma	5
Mass spectrometry-based clinical proteomics – a revival	5
Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis	5
Role of protein deimination in cardiovascular diseases: potential new avenues for diagnostic and prognostic biomarkers	5
Can proteomics-based approaches further help COVID-19 prevention and therapy?	5
How lipidomics can transform our understanding of virus infections	5
Mass spectrometry based proteome profiling of the exhaled breath condensate for lung cancer biomarkers search	5
Proteomic examination of the neuroglial secretome: lessons for the clinic	4
A proteogenomic approach to target neoantigens in solid tumors	4
Transcriptomic and functional proteomics analyses to unveil the common and unique pathway(s) of neuritogenesis induced by Russell’s viper venom nerve growth factor in rat pheochromocytoma neuronal cel	4
Transcriptomic profiling in Cutaneous Leishmaniasis patients	4
LC-MS/MS: A sensitive and selective analytical technique to detect COVID-19 protein biomarkers in the early disease stage	4
Effects of antifungal agents on the fungal proteome: informing on mechanisms of sensitivity and resistance	4
Using phosphoproteomics and next generation sequencing to discover novel therapeutic targets in patient antibodies	4
Proteomic interrogation of antibiotic resistance and persistence inEscherichia coli –progress and potential for medical research	4
Small-angle X-ray scattering for the proteomics community: current overview and future potential	4
Off-target identification by chemical proteomics for the understanding of drug side effects	3
Advances in the clinical use of metaproteomics	3
Prognostic significance of proteomics and multi-omics studies in renal carcinoma	3
Latest knowledge about changes in the proteome in microgravity	3
Standardizing and increasing the utility of lipidomics: a look to the next decade	3
Developing mass spectrometry for the quantitative analysis of neuropeptides	3
Schistosome proteomics: updates and clinical implications	3
Protein markers of spermatogenesis and their potential use in the management of azoospermia	3
Evolution of proteomics technologies for understanding respiratory syncytial virus pathogenesis	3
Proteogenomic biomarkers in colorectal cancers: clinical applications	3
Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies	3
Urinary proteomics for kidney dysfunction: insights and trends	3
New advances in quantitative proteomics research and current applications in asthma	3
An overview of proteomic methods for the study of ‘cytokine storms’	3